MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2026 International Congress

    Vitamin D Status and Levodopa Responsiveness in Parkinson Disease and Association With Gastrointestinal Symptoms

    G. Saidakhmetova, ZH. Myrzayev, G. Mussagaliyeva, D. Bagautdinov, CH. Shashkin (Almaty, Kazakhstan)

    Objective: To evaluate the association between serum vitamin D levels and clinical responsiveness to levodopa in patients with Parkinson disease and to explore potential relationships…
  • 2026 International Congress

    The UF Adaptive Deep Brain Stimulation Experience

    A. Madamangalam, D. Vuddandam, J. Cagle, J. Wong, C. de Hemptinne (Gainesville, USA)

    Objective: To describe our single center experience with implementing adaptive deep brain stimulation (aDBS) strategies into a high-volume neuromodulation center. Background: Adaptive deep brain stimulation…
  • 2026 International Congress

    Allogeneic iPSC-Derived Dopaminergic Progenitor Transplantation for Parkinson’s Disease: A Phase 1, Dose-Escalation Trial

    D. Su, X. Wang, J. Zhang, X. Zheng, J. Luo, Z. Wang, L. Ma, J. Xi, P. Yan, X. Li, F. Meng, T. Feng (Beijing, China)

    Objective: To evaluate the safety, tolerability, and preliminary efficacy of putaminal implantation of XS411 (allogeneic iPSC-derived dopaminergic progenitors) in advanced PD  (NCT07080775). Background: Parkinson’s disease (PD)…
  • 2026 International Congress

    smSAA: developing a quantitative seed amplification assay with single molecule spectroscopy

    E. Sierecki, P. Manandhar, J. Rukhaya, Y. Graves, Y. Gambin (Sydney, Australia)

    Objective: Alpha-synuclein seed amplification assays (SAA) are highly sensitive and specific for detecting endogenous alpha-synuclein (Syn) seeds and are emerging as diagnostic tools for early…
  • 2026 International Congress

    Seeing the Full Picture: How Subjective and Objective Data Capture the Daily Impact of Fluctuations in Parkinson’s disease.

    J. Pagonabarraga, F. Escamilla-Sevilla, B. La Casa-Fages, N. Lopez-Ariztegui, J. Ruiz-Martinez, R. Garcia-Ramos, J. Infante, P. Mir, O. de Fabregues, F. Valldeoriola, Y. Compta (Barcelona, Spain)

    Objective: To characterize the frequency, phenomenology, subjective relevance, and daily life impact of motor and non-motor fluctuations in a multicenter cohort of Parkinson’s disease (PD)…
  • 2026 International Congress

    Feasibility study of a portable medical device, the Neuromotor pen, as a screening tool for Parkinson’s disease in a rural northern Tanzania

    I. Terry, T. Neal, R. Haggie, W. Eliamini, S. Linus, M. Dekker, S. Urasa, D. Mushi, R. Zietsma, D. Bramwell, C. Papasavvas, C. Nye, R. Walker, C. Dotchin (Newcastle, United Kingdom)

    Objective: To evaluate the feasibility and acceptability of the Neuromotor pen (NMP) as a screening tool for Parkinson’s disease in a rural Tanzanian population. Background:…
  • 2026 International Congress

    Peripheral Inflammatory Markers and Clinical Correlations in Parkinson’s Disease Patients Carrying LRRK2 G2385R and R1628P Variants

    HX. Ding, TS. Toh, NJ. Zulkefli, NS. Zulhaimi, AN. Khairul Anuar, JW. Hor, YW. Tay, IX. Kong, YC. Pang, R. Rajasuriar, SY. Lim, AH. Tan, LC. Lit (Kuala Lumpur, Malaysia)

    Objective: To investigate plasma cytokines and chemokines with clinical correlations between Parkinson’s disease (PD) patients carrying LRRK2 p.G2385R and/or p.R1628P variants, idiopathic PD (iPD), and healthy controls.…
  • 2026 International Congress

    Levels of cytokines in the cerebrospinal fluid of patients depending on the stages of Parkinson’s disease

    B. Amonov, B. Muminov, E. Abduqodirov, R. Matmurodov, S. Jumanazarova (Tashkent, Uzbekistan)

    Objective: To study of cytokine levels in serum and cerebrospinal fluid of patients with different stages of PD. Background: The clinical course of Parkinson's disease…
  • 2026 International Congress

    Altered Diet–Microbiome Associations in Parkinson’s Disease and Prodromal REM Sleep Behavior Disorder

    S. Jo, J. Lee, H. Im, M. Choi, G. Lee, S. Chung (Seoul, Republic of Korea)

    Objective: To investigate whether disease-related microbial dysbiosis modifies the relationship between dietary intake and gut microbiome composition and function in Parkinson’s disease (PD) and idiopathic…
  • 2026 International Congress

    Lifestyle Factors as Predictors of Progression in Parkinson’s Disease

    X. Zhang, X. Chen, C. Christine, A. Hung, M. Schwarzschild, A. Ascherio, M. Flores Torres, K. Bjornevik (Boston, USA)

    Objective: To prospectively examine the associations of physical activity, smoking, caffeine intake, multivitamin use, and adherence to the MIND diet with disease progression among people…
  • « Previous Page
  • 1
  • …
  • 71
  • 72
  • 73
  • 74
  • 75
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley